Abstract: A novel CVD method for preparing a layer including refractory carbide crystals, silicon carbide crystals, wherein at least part of the layer is formed from a gas mixture containing a silicon source and an aromatic carbon source, wherein the molar C/Si ratio in said gas mixture is from about 0.85 to about 1.45. Also, layers obtainable by the method and their various uses and applications.

Abstract: A refractory carbide multilayer including a first layer, a second layer and a third layer. The first layer has an average thickness of at least 25 nm and contains at least one refractory carbide, the second layer has an average thickness of at least 25 nm and contains at least one refractory carbide, the third layer has an average thickness of at least 25 nm and contains at least one refractory carbide, and the first layer has a larger mean linear intercept section grain size than the second layer.

Abstract: The present invention is directed to an electrochemical cell based on lithium technology, comprising the following components: a positive electrode containing a cathode material, a separator made of an electrically insulating material, a negative a electrode containing an anode material, the electrodes and the separator having layer or sheet form, a liquid and/or solid ion conductor material for transportation of lithium ions between the positive and the negative electrode, the said components being sealed within a casing, wherein the positive and the negative electrode each comprise an electrically conducting structure extending through a wall of the casing for further electrical connection, characterized in that it further comprises: a reference electrode within the said casing which is electrically insulated from the positive and the negative electrode, the reference electrode having layer or sheet form comprising at least one non-metallic lithium compound, and an electrically conducting structure in layer

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.

Abstract: The present invention provides methods of detecting the presence or amount of an analyte in a sample. The methods involve contacting a surface coated with a specific binding molecule to the analyte to be detected with the sample, contacting the surface coated with the specific binding molecule to the analyte to be detected with a water-soluble conjugate having at least one carrier component, at least one linking component, at least one electrochemical signal enzyme covalently attached to the carrier component, at least one targeting element for the analyte to be detected, and forming a binding complex of the specific binding molecule coated on the surface, the analyte, and the water-soluble conjugate. The binding complex is contacted with a substrate for an electrochemical signal enzyme to form a product solution, and the presence or absence of analyte in the sample is determined.

Abstract: The present invention provides water-soluble conjugates and methods of using them in diagnostic and detection assays. Devices for performing detection and quantitation assays are also provided. In various embodiments the conjugates are useful in immunoassays and later flow assays. The invention provides methods of preparing the conjugates that result in higher yields and higher sensitivities for the assays. The invention also provides water-soluble conjugates utilizing electrochemical signal components capable of detecting analytes with very high sensitivity.

Abstract: Disclosed are methods for conducting assays of samples, such as whole blood, that may contain cells or other particulate matter. Also disclosed are systems, devices, equipment, kits and reagents for use in such methods. One advantage of certain disclosed methods and systems is the ability to rapidly measure the concentration of an analyte of interest in blood plasma from a whole blood sample without blood separation and hematocrit correction.